The global mortality rates for pancreas malignant neoplasms show significant disparities across countries. Latvia and Hungary stand out with the highest rates at 22.5 deaths per 100,000 men, while countries like Mexico and Peru exhibit much lower rates of 7.4 and 7.3, respectively. Notable year-on-year increases have been observed in Iceland (6.15%) and Bulgaria (3.11%), while Estonia and Costa Rica experienced significant decreases. Surprisingly, some major economies like the United States and the UK reported slight decreases in mortality rates.
Looking ahead, monitoring trends such as advancements in early detection technologies, global variations in healthcare resources, and shifts in lifestyle factors will be crucial in understanding future changes in pancreatic cancer mortality across different regions.
Top countries in Pancreas Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Male Deaths) Per Hundred Thousand Men, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Latvia | 22.5 | 2023 | +2.74% | +1.98% | View data |
| 2 | 2 Hungary | 22.5 | 2023 | 0% | -1.12% | View data |
| 3 | 3 Czech Republic | 21.7 | 2023 | 0% | +1.05% | View data |
| 4 | 4 Japan | 20.9 | 2023 | 0% | +0.39% | View data |
| 5 | 5 Estonia | 20.7 | 2023 | 0% | -3.24% | View data |
| 6 | 6 Slovakia | 20.1 | 2023 | 0% | -0.49% | View data |
| 7 | 7 Germany | 20 | 2023 | +1.01% | +0.82% | View data |
| 8 | 8 Slovenia | 19.8 | 2023 | +0.51% | 0% | View data |
| 9 | 9 Finland | 19.7 | 2023 | 0% | -1.55% | View data |
| 10 | 10 Austria | 19.4 | 2023 | 0% | -1.29% | View data |
